Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthijs van Luin

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
The Journal of Antimicrobial Chemotherapy|July 30, 2010
Effect of posaconazole on the pharmacokinetics of fosamprenavir and vice versa in healthy volunteersRoger J M Brüggemann, Matthijs van Luin, Engelina P H Colbers, et al.
Pediatric Rheumatology Online Journal|May 7, 2024
Adherence to low-dose methotrexate in children with juvenile idiopathic arthritis using a sensitive methotrexate assayJulia E Möhlmann, Sytze de Roock, Annelies C Egas, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|January 30, 2024
Elexacaftor/tezacaftor/ivacaftor in liver or kidney transplanted people with cystic fibrosis using tacrolimus, a drug-drug interaction studyRenske van der Meer, Erik B Wilms, Margot N Eggermont, et al.
British Journal of Clinical Pharmacology|May 17, 2020
Prospective validation of a model-informed precision dosing tool for vancomycin in intensive care patientsRob Ter Heine, Ron J Keizer, Krista van Steeg, et al.
Journal of Thrombosis and Haemostasis : JTH|September 23, 2023
Functional determination of emicizumab in presence of factor VIII activityNasim Shahidi Hamedani, Anouk Anna Marie Therese Donners, Matthijs van Luin, et al.
Pharmaceutics|May 27, 2023
Optimization of a Quantitative Anti-Drug Antibodies against Infliximab Assay with the Liquid Chromatography-Tandem Mass Spectrometry: A Method Validation Study and Future PerspectivesErin H Smeijsters, Kim C M van der Elst, Amy Visch, et al.
Antiviral Therapy|March 27, 2009
Absence of a relation between efavirenz plasma concentrations and toxicity-driven efavirenz discontinuations in the EuroSIDA studyMatthijs van Luin, Wendy P Bannister, Amanda Mocroft, et al.
Clinical Pharmacokinetics|December 11, 2025
Population Pharmacokinetics of Total and Protein-Unbound Prednisolone in Children with Immune-Mediated and Systemic Inflammatory DiseasesJulia E Möhlmann, Caroline A Lindemans, Marc H A Jansen, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 17, 2010
Drug-drug interactions between raltegravir and pravastatin in healthy volunteersMatthijs van Luin, Angela Colbers, Eleonora W J van Ewijk-Beneken Kolmer, et al.
Journal of Clinical Pharmacology|September 1, 2009
The effect of raltegravir on the glucuronidation of lamotrigineMatthijs van Luin, Angela Colbers, Corrien P W G M Verwey-van Wissen, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
The Journal of Antimicrobial Chemotherapy|July 30, 2010
Effect of posaconazole on the pharmacokinetics of fosamprenavir and vice versa in healthy volunteersRoger J M Brüggemann, Matthijs van Luin, Engelina P H Colbers, et al.
Pediatric Rheumatology Online Journal|May 7, 2024
Adherence to low-dose methotrexate in children with juvenile idiopathic arthritis using a sensitive methotrexate assayJulia E Möhlmann, Sytze de Roock, Annelies C Egas, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|January 30, 2024
Elexacaftor/tezacaftor/ivacaftor in liver or kidney transplanted people with cystic fibrosis using tacrolimus, a drug-drug interaction studyRenske van der Meer, Erik B Wilms, Margot N Eggermont, et al.
British Journal of Clinical Pharmacology|May 17, 2020
Prospective validation of a model-informed precision dosing tool for vancomycin in intensive care patientsRob Ter Heine, Ron J Keizer, Krista van Steeg, et al.
Journal of Thrombosis and Haemostasis : JTH|September 23, 2023
Functional determination of emicizumab in presence of factor VIII activityNasim Shahidi Hamedani, Anouk Anna Marie Therese Donners, Matthijs van Luin, et al.
Pharmaceutics|May 27, 2023
Optimization of a Quantitative Anti-Drug Antibodies against Infliximab Assay with the Liquid Chromatography-Tandem Mass Spectrometry: A Method Validation Study and Future PerspectivesErin H Smeijsters, Kim C M van der Elst, Amy Visch, et al.
Antiviral Therapy|March 27, 2009
Absence of a relation between efavirenz plasma concentrations and toxicity-driven efavirenz discontinuations in the EuroSIDA studyMatthijs van Luin, Wendy P Bannister, Amanda Mocroft, et al.
Clinical Pharmacokinetics|December 11, 2025
Population Pharmacokinetics of Total and Protein-Unbound Prednisolone in Children with Immune-Mediated and Systemic Inflammatory DiseasesJulia E Möhlmann, Caroline A Lindemans, Marc H A Jansen, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 17, 2010
Drug-drug interactions between raltegravir and pravastatin in healthy volunteersMatthijs van Luin, Angela Colbers, Eleonora W J van Ewijk-Beneken Kolmer, et al.
Journal of Clinical Pharmacology|September 1, 2009
The effect of raltegravir on the glucuronidation of lamotrigineMatthijs van Luin, Angela Colbers, Corrien P W G M Verwey-van Wissen, et al.
Pageof 4